Are you someone who has ‘n’ number of bottles lined in your kitchen cabinet that are labeled as supplements? And do you consume all those according to your health and necessities?
Then you might be helping yourself unknowingly!
Read on to know more.
According to a 2024 study, published in Aggression and Violent Behavior, fatty acids, available as dietary supplements via fish oil capsules and thought to help with mental and physical well-being, could also cut down on aggression.

What’s the research?

On one hand, omega-3 has previously been linked to preventing schizophrenia. On the other hand, aggression and antisocial behavior are thought in part to stem from a lack of nutrition. Now, what we eat can influence our brain’s chemistry.
Researchers from the University of Pennsylvania built on earlier, smaller studies of omega-3 supplementation effects on aggression. Their meta-analysis looked at 29 randomized controlled trials across 3,918 participants in total.
Across all the trials, a modest but noticeable short-term effect was found, translating to up to a 28 percent reduction in aggression across multiple different variables (including age, gender, medical diagnosis, and length and dosage of treatment).
The trials included in the study, carried out between 1996 and 2024, ran for an average of 16 weeks. They covered a variety of demographics, from children aged 16 and under to older people aged between 50 and 60.
Neurocriminologist Adrian Raine said, when the meta-analysis was published, “I think the time has come to implement omega-3 supplementation to reduce aggression, irrespective of whether the setting is the community, the clinic, or the criminal justice system.”

What else?

The reductions in aggression included both reactive aggression (in response to provocation) and proactive aggression (behavior pre-planned). Before this study, it wasn’t clear if omega-3 could help with these different types of aggression.
While larger studies across longer periods are going to be needed to further establish this relationship, it adds to our understanding of how fish oil pills and the omega-3 in them might be beneficial for the brain.
As per Raine, “At the very least, parents seeking treatment for an aggressive child should know that in addition to any other treatment that their child receives, an extra portion or two of fish each week could also help.”

The findings:

As per the researchers, something in the way that omega-3 reduces inflammation and keeps vital brain processes ticking over might be helping regulate aggression. There are still a lot of questions yet to be answered. However, the team suggests there’s enough evidence to look into this further.
Additionally, studies also show that medications derived from fish oil, which is a rich source of omega-3, can help reduce the risk of fatal heart attacks, strokes, and other heart health problems. As per Raine, “Omega-3 is not a magic bullet that is going to completely solve the problem of violence in society. But can it help? Based on these findings, we firmly believe it can, and we should start to act on the new knowledge we have.”

Benefits of fish oil:

Fish oil contains omega-3 fatty acids, which may have many health benefits, including:
Heart health: Fish oil may help prevent cardiovascular disease, coronary artery disease, and ischemic strokes. It may also help lower blood pressure and improve blood flow.
Brain health: Fish oil may help improve brain cell function, memory, and prevent Alzheimer’s disease.
Eye health: Fish oil may help prevent macular degeneration, the leading cause of blindness.
Joint health: Fish oil may help relieve rheumatoid arthritis and curb joint pain and stiffness.
Fetal development: Fish oil may help boost fetal development, especially of the brain and eyes.
Neurodevelopmental conditions: Fish oil may help improve attention and hyperactivity in children with conditions like ADHD.
Immune system: Fish oil may help boost the immune system.
Blood sugar levels: Fish oil may help control blood sugar levels in patients with diabetes.
Depression: Some researchers found that cultures that consume foods with high levels of omega-3s have lower levels of depression.
You can get omega-3s from fish, especially cold-water fatty fish like salmon, mackerel, and tuna. If you don’t eat fish, you can take fish oil supplements.

A new study has identified a crucial genetic mechanism that controls caffeine production in tea plants, potentially paving the way for creating tea varieties with customized caffeine levels to meet different consumer preferences.

Researchers from Hunan Agricultural University and the United States Department of Agriculture have uncovered how a specific gene called CsbHLH1 works together with a molecule called miR1446a to regulate caffeine production in tea plants. The findings were published on December 29, 2023, in Horticulture Research.

The research team analyzed various tea plant varieties using advanced techniques such as liquid chromatography-mass spectrometry and genetic analysis. They found that CsbHLH1 acts as a natural brake on caffeine production by suppressing another gene called TCS1, which is responsible for making caffeine.

“Our findings represent a significant leap forward in understanding the molecular regulation of caffeine in tea plants,” said Dr. Zhonghua Liu, the study’s lead researcher. “This could fundamentally change tea cultivation practices and lead to the development of new varieties that cater to specific consumer demands.”

The study focused on several tea varieties, including one known as ‘Jianghua Kucha’ which naturally produces higher levels of caffeine than other varieties. By comparing these different plants, the researchers were able to understand how genetic differences lead to varying caffeine levels.

One of the study’s key discoveries was how a small molecular component called miR1446a influences caffeine production. This molecule can reduce the activity of the CsbHLH1 gene, which in turn allows more caffeine to be produced. This creates a precise control system that tea plants use to regulate their caffeine levels.

The implications of this research extend beyond the laboratory. Tea producers could potentially use this knowledge to develop new varieties of tea with precisely controlled caffeine levels. This could lead to the creation of naturally low-caffeine teas for evening consumption or higher-caffeine varieties for morning beverages.

The researchers used multiple approaches to verify their findings, including analyzing tea plants where they temporarily blocked the CsbHLH1 gene’s function. When they did this, the plants produced more caffeine, confirming the gene’s role in regulating caffeine production.

While the study represents a significant advance in understanding how tea plants produce caffeine, the researchers note that several questions remain unanswered. They still need to investigate how this newly discovered genetic mechanism interacts with other factors that influence caffeine production in tea plants.

The research was supported by various organizations, including the Natural Science Foundation of Hunan Province and the National Natural Science Foundation of China, highlighting the collaborative nature of this scientific discovery.

Fertility Supplements Market Size and Forecast 2025 to 2034

The global fertility supplements market size accounted for USD 2.24 billion in 2024 and is expected to exceed around USD 4.85 billion by 2034, growing at a CAGR of 8.04% from 2025 to 2034. The growing trend of women delaying pregnancies is the key factor driving the fertility supplements market growth. Also, increasing healthcare costs coupled with advancements in the medical industry can fuel market growth soon. 

Fertility Supplements Market Key Takeaways 

• North America dominated the fertility supplements market and contributed the largest market share of 36% in 2024.
• Asia Pacific is expected to grow at the fastest CAGR of 11.13% over the studied period.
• By ingredient type, the synthetic/ blend of natural and synthetic segment has held the biggest market share of 90% in 2024.
• By ingredient type, the natural segment is expected to grow at the fastest rate over the forecast period. 
• By product, the capsule segment generated the highest market share of 41% in 2024.
• By product, the liquid segment is anticipated to grow at the fastest rate over the forecast period.
• By end-user, the women segment recorded a major market share of 55% in 2024. 
• By end-user, the men’s segment is expected to grow at the fastest during the projected period.
• By distribution channel, the OTC segment accounted for the highest market share of 78% in 2024.
• By distribution channel, the prescribed segment is projected to show the fastest growth during the forecast period.

Role of Artificial Intelligence (AI) in IVF Laboratories

In the fertility supplements market, Artificial Intelligence tools like deep learning and machine learning improve quality control, enhance precision, and increase efficiency in processes such as sperm and embryo selection. It also decreases variability and human error, hence supporting greater success rates for in-vitro fertilization treatments. Furthermore, AI has the ability to transform IVF by streamlining the outcomes, but it requires keen management to ensure moral standards that can fulfill patients’ trust.

• In October 2024, Alife Health (Alife) announced a groundbreaking partnership with Inception Fertility™ (Inception), the largest provider of comprehensive fertility services across North America, to expand access to AI technology for in vitro fertilization (IVF).

U.S. Fertility Supplements Market Size and Growth 2025 to 2034

The U.S. fertility supplements market size was evaluated at USD 640 million in 2024 and is projected to be worth around USD 1.41 billion by 2034, growing at a CAGR of 8.21% from 2025 to 2034.

North America dominated the fertility supplements market in 2024. The dominance of the region can be attributed to the increasing infertility rate along with the growing public awareness regarding health in general. However, in North America, the U.S. led the market owing to the rising demand for organic and natural products, with the presence of a strong regulatory environment that promotes a healthy lifestyle.

Asia Pacific is expected to show the fastest growth in the fertility supplements market over the studied period. The growth of the region can be linked to the enhanced availability and accessibility of healthcare facilities coupled with the growing investments in research and healthcare infrastructure. Furthermore, governments in developing countries are taking various initiatives to increase awareness about infertility.

• In April 2023, Indian pharma company Mankind Pharma set up a dedicated factory in Udaipur, Rajasthan, for the comprehensive manufacturing of Duphaston (dydrogesterone), a synthetic hormone widely utilized for preventing miscarriage and treating infertility. 

Market Overview 

Fertility supplements help to enhance hormonal profiles and increase delivery and pregnancy rates for women and men. Male infertility is mainly associated with the decreased motility of sperm and low sperm count, which can occur due to hormonal imbalance. Growing infertility has occurred because of factors like a rise in the consumption of drugs and alcohol, frequent smoking, increased stress levels, and environmental factors. Many individuals are emphasizing enhancing sexual well-being.

Top five countries by total fertility rate 2024

Fertility Supplements Market Growth Factors

• The surge in fertility rates due to the rising consumption of alcoholic beverages is expected to fuel market growth soon. 
• Growth in the number of fertility clinics can propel market growth shortly. 
• The ongoing fertility rate decline among women will likely contribute to the fertility supplements market expansion over the forecast period.

Market Scope

Market Dynamics 

Drivers

Increasing demand for natural fertility treatments

Many individuals who are trying for a baby are considering natural alternatives over traditional medical treatments like IVF. The fertility supplements market can be seen as a more secure way to increase the chances of conception naturally. In addition, fertility supplements are considered an essential segment of preconception care, because they offer the body with necessary nutrients that are required for good fertility.

• In October 2024, Premom announced the launch of its latest innovation: a premium, female doctor-formulated supplement line. Developed to meet the specific needs of women who are trying to conceive, pregnant, or postpartum, this new line underscores ongoing commitment to offering the highest quality products that support women’s health at every stage.

Restraint 

Low success rates

Effectivity concerns are a key constraint for the fertility supplements market. Patients may be in a state of dissonance regarding the efficiency of these products because of fluctuating results and less evidence supporting their effectiveness. Moreover, fertility supplements confront significant regulatory hurdles due to changing requirements and standards across different regions. 

Opportunity

E-commerce development

Availability of online in recent years, fertility supplements have earned substantial attention in the men’s and women’s health markets because of their part in supporting reproductive health. Fertility supplements emphasize improving the functionality of the uterus, fallopian tubes, and ovaries in the female reproductive system. Furthermore, players in the fertility supplements market are strengthening their online presence to make this product accessible to all customers.

• In April 2024, Perelel built upon its bestselling Conception Support Pack with the launch of Fertility+ Support, an antioxidant boost for those in the early stages of their fertility journey. The new product was launched on the brand’s e-commerce site.

Ingredient Type Insights 

The synthetic/ blend of natural and synthetic segments dominated the fertility supplements market in 2024. The dominance of the segment can be attributed to the increasing demand for these supplements by consumers as they provide benefits of both natural and synthetic nutrients. These supplements possess a blend of natural ingredients and vitamins to assist in strengthening fertility. Additionally, vitamin C, vitamin B6, Selenium, zinc, and Myo-Inositol are the primary synthetic ingredients that are easily accessible.

The natural segment is expected to grow at the fastest rate in the fertility supplements market over the forecast period. The growth of the segment can be linked to the ongoing technological advancements and launches of innovative products in the wellness and health industry. Also, these supplements have minimum side effects because they are direct extracts of plant-based products.

Product Type Insights

The capsule segment led the global fertility supplements market in 2024. The dominance of the segment can be credited to the increasing importance of microencapsulation in the fitness industry to monitor the color properties and ensure the fixed release of products. However, the high cost that comes with the packaging method is preventing market players from utilizing capsule formulation during the projected period.

The liquid segment is anticipated to grow at the fastest rate in the fertility supplements market over the forecast period. The growth of the segment can be driven by the increasing use of this product-type supplement in the form of smoothies or water. These supplements have a shorter shelf life than other types and also need to be refrigerated. In addition, for patients suffering from oesophageal challenges or pill ingestion, liquid supplements can be the best choice.

In September 2024, Ritual will launch the Fertility Support drink mix in a new window. The company said, “When Katerina Schneider was pregnant for the first time, she could not find a prenatal vitamin that checked all the boxes: clean, science-backed and vegan-certified. 

End-user Insights

In 2024, the women’s segment dominated the global fertility supplements market. The dominance of the segment is due to the increasing infertility in women due to various external factors such as obesity, excessive drinking and smoking, etc. Hence, women who are looking to have a child can use these supplements to enhance egg quality and menstrual cycle, improving overall reproductive health.

• In April 2024, Fertility Family, a leading provider of fertility supplements in the UK, announced the launch of their new product, Inofolic® AlphaPlus.This innovative new supplement is designed specifically to address the unique challenges faced by women with PCOS who have a Body Mass Index of over 25.

The men’s segment is expected to grow at the fastest rate in the fertility supplements market during the projected period. The growth of the segment is due to the low or no sperm counts in males along with the abnormal motility and sperm shape. Moreover, the unhealthy lifestyle among much of the male population is increasing the risk associated with reproductive health.

Distribution Channel Insights 

The OTC segment accounted for the majority of the fertility supplements market share in 2024. The segment’s dominance can be attributed to increasing consumer awareness about the health benefits and nutritional value of these products. Also, sales of these supplements are expected to experience steady growth in developing countries such as India and China. 

The prescribed segment is projected to show the fastest growth in the fertility supplements market during the forecast period. The growth of the segment can be driven by limited awareness among most people regarding fertility supplements. Furthermore, stringent government regulations imposed by governing authorities across the globe can impact segment growth positively. 

Fertility Supplements Market Companies

• Fairhaven Health
• Coast Science
• Lenus Pharma GesmbH
• Active Bio Life Science GmbH
• Orthomol
• Exeltis USA, Inc.
• Bionova
• Fertility Nutraceuticals LLC
• Vitabiotics Ltd.
• extreme V, Inc.
• Xena Bio Herbals Pvt. Ltd.
• Gonadosan Distribution GmbH (Fertilovit)
• InnovaMed Ltd. (Amino Expert)
• Babystart Ltd
• Crown Nutraceuticals
• Sal Nature LLC
• Yadtech
• Prega News
• PlusPlus Lifesciences LLP
• Eu Natural

Latest Announcement by Market Leaders

• In June 2024. Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, announced plans to expand into plasmid DNA (pDNA) production. The centerpiece of the project is a new development and manufacturing facility in the Woodlands, Texas (near Houston).
• In November 2024, General Mills, Inc. announced it has entered into a definitive agreement to acquire Whitebridge Pet Brands’ North American premium Cat feeding and Pet treating business from NXMH in a transaction valued at USD 1.45 billion. The business includes the Tiki Pets and Cloud Star portfolio of brands.

Recent Developments

• In August 2023, Sexual wellness brand HANX unveiled two new natural supplements – Menopause Support and Pregnancy Support. These offerings, developed in-house by HANX Co-Founder Dr. Sarah Welsh, a former NHS gynecology and obstetrics doctor, promise to provide much-needed assistance to women during crucial life stages.
• In November 2023, Los Angeles-based perinatal supplement startup Needed raised USD 14 million to study pregnant people’s nutritional needs. 

Segments Covered in the Report 

By Ingredient Type

• Natural
• Synthetic/ Blend of Natural and Synthetic

By Product

• Capsules
• Tablets
• Soft Gels
• Powders
• Liquids

By End-User

By Distribution Channel 

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa